Globally, millions of people die each year from the preventable infectious diseases – HIV, malaria and viral hepatitis (B and C).
Including tuberculosis, they are among the leading causes of morbidity and mortality in our region and affect vulnerable communities in Australia. Many of these diseases occur as comorbidities, exacerbating illness and death. An estimated 650 million people are living with a chronic infectious disease, and billions more are at risk.
Through this program, Burnet will:
- Strive to eliminate public health threats posed by several serious infectious diseases in Australia and globally aligned with disease elimination targets set by the World Health Organization
- Aim to reduce the prevalence of hepatitis C in Australia by 50 percent and stop new Australian HIV transmissions by 2020
- Make a major contribution to malaria elimination in our region.
A two-way pipeline will be created where our research discoveries can be tested in the field, and field programs inform discovery research through our long-standing connections with vulnerable target populations in Australia, Papua New Guinea, Myanmar, China and in other African, Asian and Pacific countries.